Rising labor and supply costs paired with declining reimbursements are making colonoscopy unattractive for many gastroenterologists, drawing concern from many amid a rise of advanced stage colorectal cancer.
Author: Praveen Suthrum
An advanced practice provider–led weight intervention pathway was more successful in achieving weight loss in patients with nonalcoholic fatty liver disease than standard hepatology care, according to a study presented at the 2021 Liver Meeting.
PRAGUE, April 28, 2022 /PRNewswire/ — Fujifilm has today launched a first of its kind mobile training hub at ESGE Days to help tackle some of the biggest challenges in endoscopy, as new research shows concern among endoscopists about the impact of the pandemic on cancer services.
Nearly half of the respondents in Salix Pharmaceutical’s annual patient perspective survey reported it was more challenging to manage their irritable bowel syndrome and chronic idiopathic constipation symptoms during the last 12 months.
Gain expert insights on when to use therapeutic drug monitoring proactively to improve the efficacy of biologic therapy for inflammatory bowel disease (IBD) and reactively to guide decision-making following primary nonresponse or secondary loss of response to a biologic.
The Centers for Medicare & Medicaid Services (CMS) on April 18, 2022, published its annual proposed rule for the federal fiscal year (FY) 2023 Inpatient Prospective Payment System (IPPS) and Long-Term Care Hospital (LTCH) Prospective Payment System (PPS). In addition to annual payment updates, CMS put forth several other proposals, including health equity-focused measures in hospital quality programs, stakeholder input related to documenting social determinants of health (SDoH) in inpatient claims data and a new “birthing friendly” hospital designation.
Proton pump inhibitors (PPIs) are among the most frequently prescribed medications in the world, but in many instances, they may be unnecessary. So how might this impact our patients’ health, and how can we identify those patients who should be prescribed PPIs? Dr. Peter Buch is joined by Dr. Alexander Perelman to talk about the overuse of PPIs.
Hello, Medscape! This is Mark Lewis and I’m speaking to you in March, which is Colorectal Cancer Awareness month. I’m wearing blue, which is the thematic color for this particular month and its cause and advocacy. I feel really passionately about this month because, frankly, a medical oncologist like myself is the last person who should see a patient with colorectal cancer. I know there are many debates about screening. What is the best screening modality? Should we change the age at first screening? Of course, the US Preventive Services Task Force weighed in on that last year and shifted the age…
MOWOOT II is a revolutionary non-invasive and non-pharmacological solution to chronic constipation. Developed by a team of medical professionals, MOWOOT II delivers gentle abdominal massage that speeds up intestinal transit in people with chronic constipation. Clinically proven and free from side-effects, MOWOOT II Chronic Constipation Therapy System fights constipation effectively, safely and comfortably without laxatives, enemas or colon cleansing supplements.
This week, Dr. Fred Rosenberg catches up with Dr. Mike Dragutsky, who is a practicing gastroenterologist at Gastro One, and chairman of One GI, a managed services organization with practices in five states that was envisioned, created and is guided by physicians.